Tuberculosis drug regimens and their efficacies
Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses tuberculosis drug development.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
